Topoisomerase-IIα is upregulated in malignant peripheral nerve sheath tumors and associated with clinical outcome

Journal of Clinical Oncology

Volumn 21, Issue 24, 2003, Pages 4586-4591

  Skotheim, Rolf I ^b   Kallioniemi, Anne ^b   Bjerkhagen, Bodil ^b   Mertens, Fredrik ^b   Brekke, Helge R ^b   Monni, Outi ^b   Mousses, Spyro ^b   Mandahl, Nils ^b   Sœter, Gunnar ^b   Nesland, Jahn M ^b   Smeland, Sigbjørn ^b   Kallioniemi, Olli P ^b   Lothe, Ragnhild A ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING);

ARTICLE; CANCER SURVIVAL; CHROMOSOME 17Q; CHROMOSOME ANALYSIS; CONTROLLED STUDY; DNA MICROARRAY; ENZYME ACTIVATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE PROBE; GENETIC ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; NERVE BIOPSY; NERVE SHEATH TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; ADOLESCENT; ADULT; AGED; CHROMOSOME 17; CHROMOSOME MAP; ENZYME IMMUNOASSAY; FEMALE; GENE EXPRESSION PROFILING; GENETICS; MALE; METABOLISM; MIDDLE AGED; SURVIVAL; UPREGULATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 17; DNA TOPOISOMERASES, TYPE II; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; NERVE SHEATH NEOPLASMS; SURVIVAL ANALYSIS; UP-REGULATION;

EID: 1542438624     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.07.067     Document Type: Article

References (45)

1. Woodruff JM: Pathology of the major peripheral nerve sheath neoplasms, in Weiss SW, Brooks JSJ (eds): International Academy of Pathology Monograph. Williams and Wilkins, GA, 1996, pp 129-161
2. Ducatman BS, Scheithauer BW, Piepgras DG, et al: Malignant peripheral nerve sheath tumors: A clinicopathologic study of 120 cases. Cancer 57:2006-2021, 1986
3. Korf BR: Malignancy in neurofibromatosis type 1. Oncologist 5:477-485, 2000
4. Reed N, Gutmann DH: Tumorigenesis in neurofibromatosis: New insights and potential therapies. Trends Mol Med 7:157-162, 2001
5. Stark AM, Buhl R, Hugo HH, et al: Malignant peripheral nerve sheath tumours: Report of 8 cases and review of the literature. Acta Neurochir 143:357-363, 2001
6. Ferner RE, Gutmann DH: International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis. Cancer Res 62:1573-1577, 2002
7. Wallace MR, Marchuk DA, Andersen LB, et al: Type 1 neurofibromatosis gene: Identification of a large transcript disrupted in three NF1 patients. Science 249:181-186, 1990
8. Viskochil D, Buchberg AM, Xu G, et al: Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 62:187-192, 1990
9. Cawthon RM, Weiss R, Xu GF, et al: A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell 62:193-201, 1990
10. Daston MM, Scrable H, Nordlund M, et al: The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytes. Neuron 8:415-428, 1992
11. Serra E, Puig S, Otero D, et al: Confirmation of a double-hit model for the NF1 gene in benign neurofibromas. Am J Hum Genet 61:512-519, 1997
12. Cichowski K, Shih TS, Schmitt E, et al: Mouse models of tumor development in neurofibromatosis type 1. Science 286:2172-2176, 1999
13. Vogel KS, Klesse LJ, Velasco-Miguel S, et al: Mouse tumor model for neurofibromatosis type 1: Science 286:2176-2179, 1999
14. Nigro JM, Baker SJ, Preisinger AC, et al: Mutations in the p53 gene occur in diverse human tumour types. Nature 342:705-708, 1989
15. Menon AG, Anderson KM, Riccardi VM, et al: Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. Proc Natl Acad Sci U S A 87:5435-5439, 1990
16. Legius E, Dierick H, Wu R, et al: TP53 mutations are frequenfin malignant NF1 tumors. Genes Chromosomes Cancer 10:250-255, 1994
17. Castresana JS, Rubio MP, Gomez L, et al: Detection of TP53 gene mutations in human sarcomas. Eur J Cancer 31:735-738, 1995
18. Lothe RA, Smith-Sørensen B, Hektoen M, et al: Biallelic inactivation of TP53 rarely contributes to the development of malignant peripheral nerve sheath tumors. Genes Chromosomes Cancer 30:202-206, 2001
19. Berner JM, Sørlie T, Mertens F, et al: Chromosome band 9p21 is frequently altered in malignant peripheral nerve sheath tumors: studies of CDKN2A and other genes of the pRB pathway. Genes Chromosomes Cancer 26:151-160, 1999
20. Nielsen GP, Stemmer-Rachamimov AO, Ino Y, et al: Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation. Am J Pathol 155:1879-1884, 1999
21. Kourea HP, Orlow I, Scheithauer BW, et al: Deletions of the INK4A gene occur in malignant peripheral nerve sheath tumors but not in neurofibromas. Am J Pathol 155:1855-1860, 1999
22. Mertens F, Rydholm A, Bauer HF, et al: Cytogenetic findings in malignant peripheral nerve sheath tumors. Int J Cancer 61:793-798, 1995
23. Mertens F, Dal Cin P, De Wever I, et al: Cytogenetic characterization of peripheral nerve sheath tumours: a report of the CHAMP study group. J Pathol 190:31-38, 2000
24. Lothe RA, Karhu R, Mandahl N, et al: Gain of 17q24-qter detected by comparative genomic hybridization in malignant tumors from patients with von Recklinghausen's neurofibromatosis. Cancer Res 56:4778-4781, 1996
25. Schmidt H, Wurl P, Taubert H, et al: Genomic imbalances of 7p and 17q in malignant peripheral nerve sheath tumors are clinically relevant. Genes Chromosomes Cancer 25:205-211, 1999
26. Mechtersheimer G, Otano-Joos M, Ohl S, et al: Analysis of chromosomal imbalances in sporadic and NF1-associated peripheral nerve sheath tumors by comparative genomic hybridization. Genes Chromosomes Cancer 25:362-369, 1999
27. Forozan F, Mahlamaki EH, Monni O, et al: Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data. Cancer Res 60:4519-4525, 2000
28. Monni O, Bärlund M, Mousses S, et al: Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer. Proc Natl Acad Sci U S A 98:5711-5716, 2001
29. Skotheim RI, Monni O, Mousses S, et al: New insights into testicular germ cell tumorigenesis from gene expression profiling. Cancer Res 62:2359-2364, 2002
30. Chen Y, Dougherty ER, Bittner ML: Ratio-based decisions and the quantitative analysis of cDNA microarray images. J Biomedical Optics 2:364-374, 1997
31. Mousses S, Bittner ML, Chen Y, et al: Gene expression analysis by cDNA microarrays, in Liversey FJ, Hunt SP (eds): Functional Genomics. Oxford, UK: Oxford University Press, 2000, pp 113-137
32. Lothe RA, Slettan A, Sœter G, et al: Alterations at chromosome 17 loci in peripheral nerve sheath tumors. J Neuropathol Exp Neurol 54:65-73, 1995
33. Kononen J, Bubendorf L, Kallioniemi A, et al: Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4:844-847, 1998
34. Tusher VG, Tibshirani R, Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98:5116-5121, 2001
35. Nielsen TO, West RB, Linn SC, et al: Molecular characterisation of soft tissue tumours: A gene expression study. Lancet 359:1301-1307, 2002
36. Neve RM, Lane HA, Hynes NE: The role of overexpressed HER2 in transformation. Ann Oncol 12:9-13, 2001 (suppl 1)
37. Heck MM, Hittelman WN, Earnshaw WC: Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle. Proc Natl Acad Sci U S A 85:1086-1090, 1988
38. Bronner C, Hopfner R, Mousli M: Transcriptional regulation of the human topoisomerase Ua gene. Anticancer Res 22:605-612, 2002
39. Watanabe T, Oda Y, Tamiya S, et al: Malignant peripheral nerve sheath tumours: high Ki67 labelling index is the significant prognostic indicator. Histopathology 39:187-197, 2001
40. Kellner U, Sehested M, Jensen PB, et al: Culprit and victim: DNA topoisomerase II. Lancet Oncol 3:235-243, 2002
41. Asano T, An T, Zwelling LA, et al: Transfection of a human topoisomerase II alpha gene into etoposide-resistant human breast tumor cells sensitizes the cells to etoposide. Oncol Res 8:101-110, 1996
42. Burden DA, Osheroff N: Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme. Biochim Biophys Acta 1400:139-154, 1998
43. Fry AM, Chresta CM, Davies SM, et al: Relationship between topoisomerase II level and chemosensitivity in human tumor cell lines. Cancer Res 51:6592-6595, 1991
44. Nakanishi H, Myoui A, Ochi T, et al: P-glycoprotein expression in soft-tissue sarcomas. J Cancer Res Clin Oncol 123:352-356, 1997
45. Stein U, Wunderlich V, Haensch W, et al: Expression of the MDR1 gene in bone and soft tissue sarcomas of adult patients. Eur J Cancer 29:1979-1981, 1993